Cargando…

“Targeted” Chemotherapy for Esophageal Cancer

Detalles Bibliográficos
Autores principales:	Abdo, Joe, Agrawal, Devendra K., Mittal, Sumeet K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5377046/ https://www.ncbi.nlm.nih.gov/pubmed/28421164 http://dx.doi.org/10.3389/fonc.2017.00063

Ejemplares similares

Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
por: Abdo, Joe, et al.
Publicado: (2017)

Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen
por: Abdo, Joe, et al.
Publicado: (2018)

Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen
por: Abdo, Joe, et al.
Publicado: (2019)

Immunotherapy Plus Cryotherapy: Potential Augmented Abscopal Effect for Advanced Cancers
por: Abdo, Joe, et al.
Publicado: (2018)

Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers
por: Rai, Vikrant, et al.
Publicado: (2023)

Editorial: Chemotherapy in esophageal cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Readmission after esophageal resection for esophageal cancer: incidence and risk factors
por: Singhal, Saurabh, et al.
Publicado: (2020)

Transarterial infusion chemotherapy for advanced esophageal cancer with airway stenosis
por: Zhou, Gang, et al.
Publicado: (2023)

Mean esophageal radiation dose is predictive of the grade of acute esophagitis in lung cancer patients treated with concurrent radiotherapy and chemotherapy
por: Ozgen, Aytul, et al.
Publicado: (2012)

Induction Chemotherapy Followed by Chemoradiotherapy With or Without Consolidation Chemotherapy Versus Chemoradiotherapy Followed by Consolidation Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Xiang, Mingyue, et al.
Publicado: (2022)

Construction of Biocompatible Dual-Drug Loaded Complicated Nanoparticles for in vivo Improvement of Synergistic Chemotherapy in Esophageal Cancer
por: Zhan, Wenhua, et al.
Publicado: (2020)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in locally advanced esophageal cancer: A meta-analysis
por: Wang, Jincheng, et al.
Publicado: (2022)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume
por: Liu, Xiaoling, et al.
Publicado: (2022)

Editorial: Radiotherapy for esophageal cancer: Molecular mechanism and novel targets to improve radiosensitivity
por: Liu, Yanqing, et al.
Publicado: (2023)

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
por: Godwin, P., et al.
Publicado: (2013)

The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma
por: Zheng, Yan, et al.
Publicado: (2022)

Cost-effectiveness analysis of sintilimab plus chemotherapy for advanced or metastatic esophageal squamous cell carcinoma
por: You, Maojin, et al.
Publicado: (2022)

CT-based radiomics for predicting radio-chemotherapy response and overall survival in nonsurgical esophageal carcinoma
por: Li, Chao, et al.
Publicado: (2023)

Do the Data Support Manometric Subclassifications for Ineffective Esophageal Motility?
por: Singhal, Saurabh, et al.
Publicado: (2017)

Comparison of the Gross Target Volumes Based on Diagnostic PET/CT for Primary Esophageal Cancer
por: Shi, Jingzhen, et al.
Publicado: (2021)

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma
por: Verhage, Roy J. J., et al.
Publicado: (2011)

Induction chemotherapy increases efficacy and survival rate of patients with locally advanced esophageal squamous cell carcinoma
por: Huang, Yuting, et al.
Publicado: (2022)

Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas
por: Das, Plabon Kumar, et al.
Publicado: (2021)

No survival benefit could be obtained from adjuvant radiotherapy in esophageal cancer treated with neoadjuvant chemotherapy followed by surgery: A SEER-based analysis
por: Zheng, Si-Yue, et al.
Publicado: (2022)

A Comparison Between Neoadjuvant Chemotherapy and Neoadjuvant Chemoradiotherapy in Treating Esophageal Carcinoma: A Study at a Tertiary Care Cancer Center in Suburban India
por: Shewalkar, Balaji K, et al.
Publicado: (2022)

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
por: Sun, Jiayang, et al.
Publicado: (2023)

Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer
por: Chen, Yen-Cheng, et al.
Publicado: (2022)

Hypofractionated Radiotherapy in Combination With Chemotherapy Improves Outcome of Patients With Esophageal Carcinoma Tracheoesophageal Groove Lymph Node Metastasis
por: Wang, Jian, et al.
Publicado: (2020)

Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy
por: Jiang, Dongxian, et al.
Publicado: (2023)

Identification of Phospho-Tyrosine Targets as a Strategy for the Treatment of Esophageal Adenocarcinoma Cells
por: Lee, John, et al.
Publicado: (2021)

A Nomogram for Predicting the Risk of Radiotherapy-Related Esophageal Fistula in Esophageal Cancer Patients
por: Gui, Zhongxuan, et al.
Publicado: (2022)

Effectiveness and Safety of Targeted Agents Combined With Chemoradiotherapy for the Treatment of Esophageal Cancer: A Network Meta-Analysis
por: Liu, Peng, et al.
Publicado: (2021)

(18)F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
por: Simoni, Nicola, et al.
Publicado: (2020)

The Clinical Application of Neoantigens in Esophageal Cancer
por: Gu, Yi-Min, et al.
Publicado: (2021)

Advancements in photodynamic therapy of esophageal cancer
por: Bartusik-Aebisher, Dorota, et al.
Publicado: (2022)

Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: Perioperative and Survival Outcomes
por: Ma, Xiao, et al.
Publicado: (2022)

Integrating Clinical Data and Attentional CT Imaging Features for Esophageal Fistula Prediction in Esophageal Cancer
por: Xu, Yiyue, et al.
Publicado: (2021)

Quality of life after esophageal resection
por: Svetanoff, Wendy Jo, et al.
Publicado: (2018)

Addition of Induction or Consolidation Chemotherapy in Definitive Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone for Patients With Unresectable Esophageal Cancer: A Systematic Review and Meta-Analysis
por: Wang, Jianing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aupcvku77tg1dctrvvci311blg